# Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-study-of-axitinib-versus-physicians-best-alternative-choice/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Johnny Duerinck,Stephanie Du Four,Fenne Vandervorst,Nicky D’Haene,Marie Le Mercier,Alex Michotte,A. M. Van Binst,Hendrik Everaert,Isabelle Salmon,Frank Bouttens,Vincent Verschaeve,Bart Neyns |
| Citations | 54 |
| DOI | 10.1007/s11060-016-2092-2 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2289505114 |
| PMID | 26935577 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Vincent Verschaeve](https://scholariq.org/researchers/vincent-verschaeve/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.